The German legislator’s approach to implementing the EU Health Technology Assessment (HTA) Regulation and incorporating EU joint clinical assessment (JCA) reports into the national pricing and reimbursement system is “hesitant and vague,” according to Germany-based lawyers from the law firm Hogan Lovells.
German Ordinance To Implement HTA Reg Leaves Room For Doubt
A German ordinance implementing the EU Health Technology Assessment Regulation offers little clarity on how far joint clinical assessment reports should be considered by national authorities.
More from Germany
More from Market Access
• By
About 3,500 full-time FDA employees are expected to be laid off as part of a restructuring of the Health and Human Services Department and experts questioned whether the cuts could be implemented without harming FDA’s core mission.
• By
A German ordinance implementing the EU Health Technology Assessment Regulation offers little clarity on how far joint clinical assessment reports should be considered by national authorities.
• By
A Republican think tank suggested variations of the Most Favored Nation and international reference policies in Medicare and Medicaid, as well as tariffs and other trade levers to rebalance drug pricing disparities between US countries and abroad.